Status: current, Defined. Date: 31-Mar 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4342171000168116 | Cold Sore Relief (Oraplex) (ascorbic acid 250 mg + Astragalus membranaceus extract 5 mg + citrus bioflavonoids extract 200 mg + lysine hydrochloride 625 mg + nicotinamide 10 mg + pyridoxine hydrochloride 10 mg + zinc 10 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4342181000168118 | Cold Sore Relief (Oraplex) tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cold Sore Relief (Oraplex) tablet, 30 | Is a | lysine hydrochloride 625 mg + ascorbic acid 250 mg + citrus bioflavonoids extract 200 mg + zinc 10 mg + nicotinamide 10 mg + pyridoxine hydrochloride 10 mg + membranous milk vetch extract 5 mg tablet, 30 | true | Inferred relationship | Some | ||
| Cold Sore Relief (Oraplex) tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Cold Sore Relief (Oraplex) tablet, 30 | has TP | Cold Sore Relief (Oraplex) | true | Inferred relationship | Some | ||
| Cold Sore Relief (Oraplex) tablet, 30 | has TPUU | Cold Sore Relief (Oraplex) tablet | true | Inferred relationship | Some | 518987064 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cold Sore Relief (Oraplex) tablet, 30, bottle | Is a | True | Cold Sore Relief (Oraplex) tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR